- Four new investments, and four new exits
- Over 15% average topline growth across portfolio companies in 2018
- Over 30% value creation in the portfolio
- Montefiore Investment strengthens its position as the top-performing French GP over the long term
For several years now, Montefiore Investment has been recognized by French and international investors as the best-performing GP, both for its achievements and for those of the SMEs it partners with.
Key highlights of 2018 include:
1) Average topline and EBITDA growth of over 15%, across all 15 companies in the portfolio, for the 8 th year in a row. This result has been driven:
- Half by organic growth – about 5 times faster than French GDP growth – and market share gains of each portfolio company
- Half by external growth, with 14 transactions closed in 2018 by portfolio companies
2) Four new investments, creating French leaders in the following sectors: document archiving, distribution of saving plans, debt servicing and purchasing, and electronic security.
3) Four new exits, which crystalize the successful, transforming growth of portfolio companies:
- Biolab, medical biology specialist, was acquired by Eurofins, a world leader in diagnosis, after having multiplied its revenues by 2.5 in just four years and built a leading position in its region.
- DSO Group, receivables management specialist, merged with MCS, after having multiplied its activity by 3.1x in four years.
- Montefiore Investment, together with Carlyle, sold a minority stake in European Camping Group to OTPP, a top-tier Canadian investor, after having accelerated the development of the European leader in mobile home holidays, with revenues multiplied by 4 in four years.
- Montefiore Investment sold part of its investment in Voyageurs du Monde to Groupe CIC, three years after its initial investment, supporting a strong acceleration in the Group’s profitable growth, in France and internationally.
